TNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ Report


New York, NY -- April 12, 2022 -- InvestorsHub NewsWire -- via Traders News Source -- Traders News Source, a leading independent equity research and corporate access firm focused on small cap growth companies issues new research.

Emerging EV producer Mullen Automotive, Inc. (NASDAQ: MULN) is trying to make a comeback after losing nearly half its value this year. That effort was aided by an apparent short squeeze that saw the company shares quadruple over a 2-week period last month. Short interest in Mullen shares continues to hover around 25% of the available shares and some investors are wondering if another short squeeze may be around the corner. Last week, Sunshine Biopharma, Inc. (NASDAQ: SBFM) announced that two of its newly designed mRNA molecules are effective at destroying cancer cells grown in culture and the company shares gained significantly on the news. Dr. Steve Slilaty, CEO of Sunshine Biopharma said, “The potential use of mRNA to treat cancer opens the door to many possibilities for patients including convenience, reduced toxicity and enhanced efficacy.”

Will a short squeeze happen at MULN near-term? Is SBFM on the verge of an oncology breakthrough? READ MORE
Copy and paste to browser may be required-

Northwest Biotherapeutics, Inc. (OTCQB: NWBO) a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, after spending years in preparation, is now operating under the UK Medicines and Healthcare Products Regulatory Agency (MHRA) license for manufacture of GMP (clinical grade) cell therapy products. The company is in production of its first dendritic cell cancer vaccine at its new facility. The giant home mortgage servicing company, Mr. Cooper Group Inc. (NASDAQ: COOP) recently announced an agreement with Sagent M&C, LLC, d/b/a Sagent Lending Technologies. This agreement will leverage Mr. Cooper’s mortgage servicing depth and Sagent’s software innovation speed to create the industry’s first cloud-native, homeowner-first servicing platform.

Will DCVax be a successful product for NWBO? How exactly will COOP benefit from the new Sagent agreement? READ MORE
Copy and paste to browser may be required –


Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a chartered financial analyst, for further information on analyst credentials, please email TNS LLC provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer be featured on our coverage list, contact us via email at:

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Traders News Source


Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Mar 2023 to Mar 2023 Click Here for more Northwest Biotherapeutics (QB) Charts.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Northwest Biotherapeutics (QB) Charts.